Clinical Research Directory
Browse clinical research sites, groups, and studies.
HRQoL in Patients With Solid Tumors Treated With Hadrontherapy
Sponsor: CNAO National Center of Oncological Hadrontherapy
Summary
The Quality of Life of patients treated with hadrontherapy is still limited. Two cohorts are established, they will be receiving specific standardized questionnaires to be evalutaed in their results.
Official title: Health Related Quality of Life (HRQoL) in Patients With Solid Tumors Treated With Hadrontherapy (HadroQoL).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
180
Start Date
2023-03-27
Completion Date
2025-09-26
Last Updated
2025-08-06
Healthy Volunteers
No
Interventions
questionnaires administration
Enrolled people will be requested to fill in questionnaires. Cohort A affected by head and neck cancer: SF-12, EORTC QLQ-C30, EORTC QLQ-H\&N43, HADS, Brief COPE, BRCS. Cohort A affected by skull base/brain cancer: SF-12, EORTC QLQ-BN20, HADS, Brief COPE, BRCS. Cohort B will receive: EORTC QLQ-C30, BRCS, PROFFIT, SF-12, EORTC QLQ-H\&N43.
Locations (1)
CNAO
Pavia, Pv, Italy